Skip to main content
. Author manuscript; available in PMC: 2019 Oct 7.
Published in final edited form as: HPB (Oxford). 2018 Jan 12;20(7):597–604. doi: 10.1016/j.hpb.2017.12.010

Table 3.

CEACAM 1/5 and tenascin C staining intensity and pattern differentiates patients with PDAC from IPMN without microinvasive cancer.

PDAC (n=27) IPMN (n=12) p-value

CEACAM 1/5 staining on tumor epithelial cells

Staining intensity
 Weak (1) 0 (0%) 0 (0%) 0.401
 Moderate (2) 7 (26%) 2 (17%)
 Strong (3) 20 (74%) 10 (83%)

Staining pattern
 Membranous + luminal 23 (0 focal, 23 diffuse) 6 (1 focal, 5 diffuse) 0.026
 Membranous only 1 (1 focal, 0 diffuse) 0 (0 focal, 0 diffuse)
 Luminal only 3 (2 focal, 1 diffuse) 6 (4 focal, 2 diffuse)

Total score on membranous part of epithelial tumor cells
 < 4 4 (15%) 6 (50%) 0.020
 ≥ 4 23 (85%) 6 (50%)

Tenascin C staining on stroma

Staining intensity
 Weak (1) 0 (0%) 4 (33%) 0.002
 Moderate (2) 10 (37%) 6 (50%)
 Strong (3) 17 (63%) 2 (17%)

Staining pattern
 Focal (1) 13 (48%) 12 (100%) 0.002
 Diffuse (2) 14 (52%) 0 (0%)

Total score
 < 4 8 (30%) 10 (83%) 0.002
 ≥ 4 19 (70%) 2 (17%)

PDAC, pancreatic ductal adenocarcinoma; IPMN, intraductal papillary mucinous neoplasm The staining pattern was scored as negative (0), focal (1), and diffuse (2), while staining intensity was scored as weak (1), moderate (2), or strong (3). The expression for CEACAM 1/5 and tenascin C was accepted as positive if a total score of ≥ 4 was obtained from combined staining intensity and pattern.